Tempest Therapeutics, Inc. (TPST) Form 10-Q Quarterly Reports
Tempest Therapeutics, Inc. (TPST) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TPST
CIK: 1544227
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerAndrew Jadin
Audit LocationChicago, Illinois, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| PRE 14A | 2026-10-16 | 2026-11-09 | PRELIMINARY PROXY STATEMENT | 0001213900-26-110304 | View SEC Doc Filr Page |
| D | 2026-10-14 | — | D Filing | 0001213900-26-109190 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-22 | 4 Filing | 0001213900-26-106400 | View SEC Doc Filr Page |
| 3 | 2026-10-02 | 2026-09-22 | 3 Filing | 0001213900-26-106399 | View SEC Doc Filr Page |
| 424B3 | 2026-10-02 | — | PROSPECTUS | 0001213900-26-106362 | View SEC Doc Filr Page |
| EFFECT | 2026-10-01 | — | EFFECT Filing | 9999999995-26-003135 | View SEC Doc Filr Page |
| 8-K | 2026-09-28 | 2026-09-22 | CURRENT REPORT | 0001213900-26-104034 | View SEC Doc Filr Page |
| S-3 | 2026-09-25 | — | REGISTRATION STATEMENT | 0001213900-26-103526 | View SEC Doc Filr Page |
| 8-K | 2026-09-17 | 2026-09-14 | 8-K | 0001193125-26-394492 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-16 | — | DEFA14A | 0001193125-26-393155 | View SEC Doc Filr Page |
| 8-K | 2026-09-16 | 2026-09-15 | 8-K | 0001193125-26-393151 | View SEC Doc Filr Page |
| 8-K | 2026-09-15 | 2026-09-11 | 8-K | 0001193125-26-391903 | View SEC Doc Filr Page |
| 424B3 | 2026-09-01 | — | 424B3 | 0001193125-26-378588 | View SEC Doc Filr Page |
| EFFECT | 2026-08-31 | — | EFFECT Filing | 9999999995-26-002838 | View SEC Doc Filr Page |
| CORRESP | 2026-08-27 | — | CORRESP Filing | 0001193125-26-371259 | View SEC Doc Filr Page |
| UPLOAD | 2026-08-27 | — | UPLOAD Filing | 0000000000-26-008466 | View SEC Doc Filr Page |
| 8-K | 2026-08-24 | 2026-08-18 | 8-K | 0001193125-26-363695 | View SEC Doc Filr Page |
| S-1 | 2026-08-21 | — | S-1 | 0001193125-26-361240 | View SEC Doc Filr Page |
| DEFA14A | 2026-08-18 | — | DEFA14A | 0001193125-26-355565 | View SEC Doc Filr Page |
| 8-K | 2026-08-18 | 2026-08-17 | 8-K | 0001193125-26-355550 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001193125-26-349381 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001193125-26-349374 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001193125-26-349334 | View SEC Doc Filr Page |
| DEFA14A | 2026-07-28 | — | DEFA14A | 0001193125-26-321197 | View SEC Doc Filr Page |
| 8-K | 2026-07-28 | 2026-07-27 | 8-K | 0001193125-26-321176 | View SEC Doc Filr Page |